4篇
您的检索式：作者名="Kengo Yasuda"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | ALK Gene Translocation in Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report显示文摘 | Kimiaki Takagi Manabu Takai Koji Kameyama Kengo Horie Mina Kikuchi Taku Kato Kosuke Mizutani Kensaku Seike Tomohiro Tsuchiya Mitsuru Yasuda Shigeaki Yokoi Natsuko Suzui Masahiro Nakano Takashi Deguchi | 2015 | Urology Case Reports2015，，5： | 1 |
| 2 | Inverse correlation between reactive oxygen species in unwashed semen and sperm motion parameters as measured by a computer-assisted semen analyzer显示文摘这研究调查了在一个帮助计算机的精液分析器和反应的氧种类的层次在未洗涤的精液获得的精子运动参数之间的关联。总共, 847 个病人,除了 azoospermic,病人们被调查。在每个病人的时候第一咨询,精液参数用 SMAS 被测量或反应的氧种类的 CellSoft 3000,和生产用一个计算机驱动的 LKB Wallac 光度计被测量 1251 分析器。病人被划分成二个组:反应的氧种类 - 积极、否定。在每个组以内的精液参数用二个帮助计算机的精液分析器系统之一被测量然后比较。在在从反应的氧种类的精液的反应的氧种类层次和精子运动参数之间的关联 - 积极的组也被调查。反应的氧种类在 282 个案例(33.3%) 的精液样品被检测。精子集中(P < 0.01;P < 0.01 ) ,活动性(P < 0.01;P < 0.05 ) ,并且进步活动性(P < 0.01;P < 0.01 ) 在反应的氧种类是显著地更低的 - 积极的组比在反应的氧种类 - 否定的组。在在反应的氧种类的精子运动参数之中 - 积极的组,精子集中(P < 0.01;P < 0.01 ) ,活动性(P < 0.05;P < 0.01 ) , mALH (P < 0.05;P < 0.01 ) ,并且进步活动性(P < 0.05;P < 0.01 ) 与对数的转变的反应的氧种类层次的也显示出的反的关联。因此,这研究在精液损坏精子集中,活动性,和另外的精子运动表明了那过多的反应的氧种参数。 | Teppei Takeshima Yasushi Yumura Kengo Yasuda Hiroyuki Sanjo Shinnosuke Kuroda Hiroyuki Yamanaka Akira Iwasaki | 2017 | Asian Journal of Andrology2017，19，3： | 1 |
| 3 | Limitations of transjugular intrahepatic portosystemic shunt for management of gastric varices显示文摘 | Akio Matsumoto Masanori Matsushita Yasushi Sugano Kengo Takimoto Mitsunori Yasuda Hideto Inokuchi | 2004 | Gastroenterology2004，，1： | 1 |
| 4 | Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma显示文摘BACKGROUND Hepatocellular carcinoma(HCC)in hepatitis C virus(HCV)-infected patients has a high risk of recurrence.Although eradication of HCV is expected to reduce this risk,the risk in patients with a history of HCC may be high after treatment with direct-acting antivirals(DAAs).AIM To determine the risk factors for HCC recurrence in patients with HCV and a history of HCC.METHODS The risk of HCC recurrence in patients with a history of HCC and/or of HCC occurrence in patients without a history of HCC after DAA therapy was retrospectively analyzed in 311 HCV patients treated at our institution and several neighboring hospitals.The frequency and predictors of HCC recurrence/occurrence after DAA treatment were included in these analyses.The clinical course of HCC before and after DAA treatment was also evaluated.RESULTS HCV patients with a history of HCC were older and had greater progression of liver fibrosis and diabetes than patients without a history of HCC.Median recurrence-free survival(RFS)was 1092 d in patients with a history of HCC,and post-DAA HCC recurrence/occurrence was observed in 29 patients(53.7%)with and 5(1.9%)without a history of HCC over 6 years(P<0.001).RFS in patients with a history of HCC did not differ significantly before and after DAA treatment.The frequency of HCC recurrence/occurrence in patients with a history of HCC was lower after than before DAA treatment.Multivariate analysis showed that the incidence rate of HCC recurrence/occurrence before DAA treatment was the only independent predictor of HCC recurrence/occurrence after DAA treatment.Liver function was well preserved and clinical course was good in patients with HCC recurrence/occurrence after DAA therapy.CONCLUSION DAA therapy in patients infected with HCV is also effective in patients with a history of HCC.Curative treatment for HCC is desirable before DAA therapy.The frequency of HCC recurrence/occurrence before DAA therapy was associated with a significantly increased risk of HCC recurrence after DAA therapy.Careful observation after DAA therapy is required in patients with a history of HCC. | Kazuto Tajiri Hiroyuki Ito Kengo Kawai Yoshiro Kashii Yuka Hayashi Aiko Murayama Masami Minemura Terumi Takahara Yukihiro Shimizu Ichiro Yasuda | 2022 | World Journal of Hepatology2022，14，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员